Sonoma Biotherapeutics is a clinical-stage biotechnology company developing engineered regulatory T cell therapies. "Sonoma Biotherapeutics, Regeneron Announce Collaboration to Discover, Develop and Commercialize Treg Cell Therapies for Autoimmune Diseases," published at 7:30 a.m. ET, and a subsequent headline incorrectly included the ticker code SNOA for Sonoma Pharmaceuticals Inc.

(END) Dow Jones Newswires

March 28, 2023 08:10 ET (12:10 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.
Regeneron Pharmaceuticals (NASDAQ:REGN)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Regeneron Pharmaceuticals Charts.
Regeneron Pharmaceuticals (NASDAQ:REGN)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Regeneron Pharmaceuticals Charts.